Marlborough, MA, United States of America

Li Shi

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li Shi. Retrieved from https://idiyas.com/inventor/li-shi-1wf5i8e5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Li Shi in HPV Vaccine Development

Introduction

Li Shi is a notable inventor based in Marlborough, MA (US), recognized for his significant contributions to the field of pharmaceutical compositions, particularly in the development of vaccines. His work focuses on creating effective solutions to combat human papillomavirus (HPV), a major health concern worldwide.

Latest Patents

Li Shi holds a patent for "Papillomavirus vaccine compositions." This invention relates to pharmaceutical compositions that comprise virus-like particles (VLPs) of HPV, which are adsorbed to an aluminum adjuvant. The patent also includes an ISCOM-type adjuvant that consists of a saponin, cholesterol, and a phospholipid. In preferred embodiments, the aluminum adjuvant is made up of amorphous aluminum hydroxyphosphate sulfate. Additionally, the invention provides multi-dose HPV vaccine formulations that include HPV VLPs and an antimicrobial preservative selected from m-cresol, phenol, and benzyl alcohol. The methods described in the patent aim to induce an immune response against HPV in human patients and prevent HPV infection.

Career Highlights

Li Shi is currently employed at Merck Sharp & Dohme Corp., where he continues to advance his research and development efforts in vaccine technology. His innovative approach to vaccine formulation has the potential to significantly impact public health by providing effective prevention against HPV.

Collaborations

Throughout his career, Li Shi has collaborated with talented professionals, including Janine Bryan and Michelle K Brownlow. These collaborations have fostered a productive environment for innovation and have contributed to the success of his projects.

Conclusion

Li Shi's work in the development of HPV vaccine compositions exemplifies the importance of innovation in the pharmaceutical industry. His contributions not only advance scientific knowledge but also hold the promise of improving health outcomes for individuals at risk of HPV infection.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…